Stereotaxis installs first robotic navigation system in Latvia

Thu, 22 Oct 2026 08:05:04 -0400

Stereotaxis (NYSE: STXS) announced that Pauls Stradiņš Clinical University Hospital in Riga, Latvia, has installed the Genesis Robotic Magnetic Navigation System, establishing what the company claims is the first robotic center for the treatment of cardiac arrhythmias in the country.

The hospital has completed initial procedures using the system, treating patients with a range of arrhythmia conditions. The Genesis system is designed for use in cardiac ablation, a minimally invasive procedure used to address abnormal heart rhythms.

"The introduction of the advanced Genesis technology at Pauls Stradiņš Clinical University Hospital reflects the hospital's long-term commitment to developing highly specialized, modern, and patient

Stereotaxis Announces First Robotic Magnetic Navigation System in Latvia

Thu, 22 Oct 2026 08:04:00 -0400

Pauls Stradiņš Clinical University Hospital installs Genesis Robotic Magnetic Navigation System, establishing the first robotic program for the treatment of cardiac arrhythmia in Latvia
First procedures successfully treated patients with a broad range of arrhythmia

ST. LOUIS, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that Pauls Stradiņš Clinical University Hospital in Riga, Latvia, has established the first robotic center for the treatment of cardiac arrhythmias in Latvia and has successfully treated initial patients with the Genesis Robotic Magnetic

Stereotaxis Announces First Robotic Magnetic Navigation System in Latvia

Thu, 22 Oct 2026 08:04:00 -0400

Pauls Stradiņš Clinical University Hospital installs Genesis Robotic Magnetic Navigation System, establishing the first robotic program for the treatment of cardiac arrhythmia in Latvia
First procedures successfully treated patients with a broad range of arrhythmia

Stereotaxis to Report Third Quarter 2026 Financial Results on November 10, 2026

Tue, 20 Oct 2026 07:40:00 -0400

ST. LOUIS, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2026 third quarter on Tuesday, November 10, 2026 at the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m. EST that day to discuss the Company’s results and corporate developments.

What:

Stereotaxis third quarter 2026 financial results conference call

When:

Tuesday, November

Stereotaxis to Report Third Quarter 2026 Financial Results on November 10, 2026

Tue, 20 Oct 2026 07:40:00 -0400

What:

Stereotaxis third quarter 2026 financial results conference call

When:

Tuesday, November

Stereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart Rhythm Society’s HRX 2026

Wed, 16 Sep 2026 07:59:00 -0400

New digital technologies, including Synchrony and SynX, will be featured at HRX
Stereotaxis CEO to join main-stage panel on Autonomous EP Systems

ST. LOUIS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that its portfolio of digital and robotic technologies will be featured at Heart Rhythm Society’s HRX conference, taking place September 18-20, 2026, in Atlanta, Georgia.

Pioneered by the Heart Rhythm Society, HRX brings together clinicians, engineers, and entrepreneurs to explore advances

Stereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart Rhythm Society’s HRX 2026

Wed, 16 Sep 2026 07:59:00 -0400

New digital technologies, including Synchrony and SynX, will be featured at HRX
Stereotaxis CEO to join main-stage panel on Autonomous EP Systems

Pioneered by the Heart Rhythm Society, HRX brings together clinicians, engineers, and entrepreneurs to explore advances

University of Szeged Celebrates Strongest First Month of Robotic Cardiology Program

Thu, 03 Sep 2026 07:56:00 -0400

University of Szeged installed Hungary’s first Robotic Magnetic Navigation system in July
Over 70 patients with all forms of arrhythmia treated robotically to date, a record pace of use globally
Robotics enabled successful treatment of patients with multiple previously failed ablation procedures
University of Szeged to celebrate leadership in technology and grand opening of Robotic Cardiology Program at upcoming scientific symposium on September 8th

ST. LOUIS, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that the Electrophysiology team at

University of Szeged Celebrates Strongest First Month of Robotic Cardiology Program

Thu, 03 Sep 2026 07:56:00 -0400

University of Szeged installed Hungary’s first Robotic Magnetic Navigation system in July
Over 70 patients with all forms of arrhythmia treated robotically to date, a record pace of use globally
Robotics enabled successful treatment of patients with multiple previously failed ablation procedures
University of Szeged to celebrate leadership in technology and grand opening of Robotic Cardiology Program at upcoming scientific symposium on September 8th

Stereotaxis (STXS) PT Lowered to $3 at Citizens on Top-Line Miss, Guidance Cut

Form 8-K Stereotaxis, Inc. For: Aug 11

Tue, 11 Aug 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260811/26905591.html

StreetInsider.com News Articles

Stereotaxis installs first robotic navigation system in Latvia

Stereotaxis Announces First Robotic Magnetic Navigation System in Latvia

Stereotaxis Announces First Robotic Magnetic Navigation System in Latvia

Stereotaxis to Report Third Quarter 2026 Financial Results on November 10, 2026

Stereotaxis to Report Third Quarter 2026 Financial Results on November 10, 2026

Stereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart Rhythm Society’s HRX 2026

Stereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart Rhythm Society’s HRX 2026

University of Szeged Celebrates Strongest First Month of Robotic Cardiology Program

University of Szeged Celebrates Strongest First Month of Robotic Cardiology Program

Stereotaxis (STXS) PT Lowered to $3 at Citizens on Top-Line Miss, Guidance Cut

Stereotaxis (STXS) PT Lowered to $3 at Citizens on Top-Line Miss, Guidance Cut

Form SCHEDULE 13G Stereotaxis, Inc. Filed by: Kaufman Daniel Louis

Form SCHEDULE 13G Stereotaxis, Inc. Filed by: Kaufman Daniel Louis

Form EFFECT Stereotaxis, Inc.

Form EFFECT Stereotaxis, Inc.

Form EFFECT Stereotaxis, Inc.

Form EFFECT Stereotaxis, Inc.

Form 424B3 Stereotaxis, Inc.

Form 424B3 Stereotaxis, Inc.

Form 424B3 Stereotaxis, Inc.

Form 424B3 Stereotaxis, Inc.

Form 10-Q Stereotaxis, Inc. For: Jun 30

Form 10-Q Stereotaxis, Inc. For: Jun 30

Stereotaxis (STXS) PT Lowered to $3 at TD Cowen

Form 8-K Stereotaxis, Inc. For: Aug 11